Unilife — FY2014 Earnings Presentation
6 slides from Unilife's earnings presentation, Sep 10, 2014
Slide 1: Fiscal 2014 4th Quarter and Full Year Earnings Call
Exhibit 99.2 Fiscal 2014 4th Quarter and Full Year Earnings Call September 9, 2014
Slide 2: Growing Rapidly in Response to Customer Demand
Growing Rapidly in Response to Customer Demand Increasing Revenue, Deferred Revenue and Cash Receipts Increasing R&D Investment $25.00 55% $20.00 50% $15.00 45% $10.00 40% $5.00 35% $- 30% FY 2012 FY 2013 FY 2014 FY 2012 FY 2013 FY 2014 Revenue Deferred Revenue Cash Receipts from Customers R&D SG&A
Slide 3: Execution on Existing Agreements and Programs
Execution on Existing Agreements and Programs A Dozen Active Customer Programs Accelerating Production Capabilities • A dozen active programs as of June 30, 2014 • Brought forward $16MM in cap-ex, R&D and facilities investments into Q4FY14 to support • Programs span across all six product platforms
Slide 4: Results for the 4th Quarter and Full Fiscal Year 2014
th Results for the 4 Quarter and Full Fiscal Year 2014 4Q 2014 4Q 2013 FY 2014 FY 2013 Revenue $ 6.5M $ 0.7M $ 14.7M $ 2.7M Research & development $ 11.9M $ 6.5M $ 34.1M $ 21.7M Selling, general & administrative $ 8.0M $ 10.3M $ 27.9M $ 32.4M Net loss $ 15.3M $ 22.0M $ 57.9M $ 63.2M Net loss per sha
Slide 5: Upcoming Milestones for Fiscal Year 2015
Upcoming Milestones for Fiscal Year 2015 Commercial Expectations • Commenced commercial sale of Unifill syringes • Commercial sale of additional Unifill product configurations to commence mid-fiscal year • Initial product sales from some other platforms • Receipt of upfront and milestone-based payme
Slide 6: Questions
Uniuice™ | Questions = uniuire™ - Gem